Evidence map›Paper›PMID 12183568›Full record

ArticleInfection and immunity2002

Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia.

Xianyuan Song, Scott Shapiro, David L Goldman, Arturo Casadevall, Matthew Scharff, Sunhee C Lee

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Receptors on Microglia.Advances in neurobiology · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xianyuan SongDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Scott Shapiro
David L Goldman
Arturo Casadevall
Matthew Scharff
Sunhee C Lee
Albert Einstein College of Medicine · USPediatrics and Genetics · USYeshiva University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Microglia, Cytokines and HIVR01MH055477 · NIMH · YESHIVA UNIVERSITY · PI LEE, SUNHEE C · 1995 to 2011
$4.1M
MOLECULAR PATHOGENESIS OF INFECTIOUS DISEASEST32AI007506 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2012
$3.7M
MECHANISM OF ANTIBODY PROTECTION TO C NEOFORMANSR01AI043937 · NIAID · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1999 to 2003
$1.6M
PATHOGENESIS OF CRYPTOCOCCAL MENINGOENCEPHALITISR01AI044641 · NIAID · YESHIVA UNIVERSITY · PI LEE, SUNHEE C · 1999 to 2002
$952k
NIAID NIH HHS AI07506NIAID NIH HHS AI43937NIAID NIH HHS AI44641NIAID NIH HHS R01 AI043937NIAID NIH HHS T32 AI007506NIGMS NIH HHS T32 GM007288NIGMS NIH HHS T32 GM07288NIMH NIH HHS MH55477NIMH NIH HHS R01 MH055477
6 · The paper itself

Abstract

Microglial cell phagocytic receptors may play important roles in the pathogenesis and treatment of several neurological diseases. We studied microglial Fc receptor (FcR) activation with respect to the specific FcgammaR types involved and the downstream signaling events by using monoclonal antibody (MAb)-coated Cryptococcus neoformans immune complexes as the stimuli and macrophage inflammatory protein 1alpha (MIP-1alpha) production as the final outcome. C. neoformans complexed with murine immunoglobulin G (IgG) of gamma1, gamma2a, and gamma3, but not gamma2b isotype, was effective in inducing MIP-1alpha in human microglia. Since murine gamma2b binds to human FcgammaRII (but not FcgammaRI or FcgammaRIII), these results indicate that FcgammaRI and/or FcgammaRIII is involved in MIP-1alpha production. Consistent with this, an antibody that blocks FcgammaRII (IV.3) failed to inhibit MIP-1alpha production, while an antibody that blocks FcgammaRIII (3G8) did. An anti-C. neoformans MAb, 18B7 (IgG1), but not its F(ab')(2), induced extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase kinase phosphorylation, and MIP-1alpha release was suppressed by the ERK inhibitor U0126. C. neoformans plus 18B7 also induced degradation of I-kappaBalpha, and MIP-1alpha release was suppressed by the antioxidant NF-kappaB inhibitor pyrrolidine dithiocarbamate. To confirm the role of FcR more directly, we isolated microglia from wild-type and various FcR-deficient mice and then challenged them with C. neoformans plus 18B7. While FcgammaRII-deficient microglia showed little difference from the wild-type microglia, both FcgammaRI alpha-chain- and FcgammaRIII alpha-chain-deficient microglia produced less MIP-1alpha, and the common Fc gamma-chain-deficient microglia showed no MIP-1alpha release. Taken together, our results demonstrate a definitive role for FcgammaRI and FcgammaRIII in microglial chemokine induction and implicate ERK and NF-kappaB as the signaling components leading to MIP-1alpha expression. Our results delineate a new mechanism for microglial activation and may have implications for central nervous system inflammatory diseases.

Indexed as

AnimalsAntibodies, BacterialAntibodies, MonoclonalAntigen-Antibody ComplexCells, CulturedCentral Nervous System DiseasesChemokine CCL3Chemokine CCL4Cryptococcus neoformansHumansMacrophage Inflammatory ProteinsMiceMicrogliaMitogen-Activated Protein KinasesNF-kappa BReceptors, IgGAntibodies, BacterialAntibodies, MonoclonalAntigen-Antibody ComplexChemokine CCL3Chemokine CCL4Macrophage Inflammatory ProteinsMitogen-Activated Protein KinasesNF-kappa BReceptors, IgG

Identifiers

PMID12183568
PMCPMC128255
OpenAlexW2142634105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.